03:44 PM EST - Aeterna Zentaris Inc. : announced that the European Patent Office has granted a patent for the use of alkyl phosphocholines, more specifically perifosine (octadecyl 1,1-dimethylpiperidino-4-yl phosphate), in the preparation of a medicament for the treatment of benign and malignant tumours, prior to and/or during the treatment with approved anti-tumour anti-metabolites such as 5FU ("fluorouracil") and capecitabine. Aeterna Zentaris Inc.
shares T.AEZ are trading up $0.03 at $2.25.
